![Francesco DeRubertis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Francesco DeRubertis
Direttore/Membro del Consiglio presso Palladio Biosciences, Inc.
Posizioni attive di Francesco DeRubertis
Società | Posizione | Inizio | Fine |
---|---|---|---|
Palladio Biosciences, Inc.
![]() Palladio Biosciences, Inc. BiotechnologyHealth Technology Palladio Biosciences, Inc. develops transformative medicines for orphan diseases. Its pipeline includes Lixivaptan, a selective vasopressin V2 receptor antagonist for the treatment of polycystic kidney disease, a life-threatening genetic disease. The company was founded by Lorenzo Pellegrini in 2015 and is headquartered in Newtown, PA. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Francesco DeRubertis
Statistiche
Distribuzione geografica
Stati Uniti | 2 |
Posizioni
Director/Board Member | 1 |
Settori
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Palladio Biosciences, Inc.
![]() Palladio Biosciences, Inc. BiotechnologyHealth Technology Palladio Biosciences, Inc. develops transformative medicines for orphan diseases. Its pipeline includes Lixivaptan, a selective vasopressin V2 receptor antagonist for the treatment of polycystic kidney disease, a life-threatening genetic disease. The company was founded by Lorenzo Pellegrini in 2015 and is headquartered in Newtown, PA. | Health Technology |
- Borsa valori
- Insiders
- Francesco DeRubertis
- Esperienza